Watchlist Price Alert

Sage Therapeutics Inc. (SAGE)

NASDAQ: SAGE · Real-Time Price · USD

9.06

2.36 (35.22%)

At close: Jun 16, 2025, 3:59 PM

9.06

0.00%

Pre-market: Jun 17, 2025, 09:02 AM EDT

Sage Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	41.24M	86.45M	7.69M	6.31M	1.11B	6.87M	90.27M	n/a	n/a
Cost of Revenue	9.44M	2.16M	813K	553K	565K	400K	1.1M	500K	281K
Gross Profit	31.8M	84.3M	6.87M	5.75M	1.11B	6.47M	89.17M	-500K	-281K
Operating Income	-432.37M	-579.85M	-546.99M	-460.91M	596.23M	-708.12M	-393.24M	-273.15M	-160.16M
Interest Income	31.68M	38.74M	14.19M	2.88M	9.6M	27.8M	20.33M	3.1M	1.21M
Pretax Income	-400.67M	-541.49M	-532.78M	-457.89M	606.07M	-680.24M	-372.88M	-270.12M	-158.99M
Net Income	-400.67M	-541.49M	-503.27M	-450.83M	606.07M	-650.15M	-372.88M	-270.12M	-158.99M
Selling & General & Admin	216.42M	274.52M	227.7M	183.5M	196.95M	345.78M	201.4M	62.88M	39.41M
Research & Development	225.9M	356.24M	326.16M	283.17M	292.71M	368.81M	282.11M	210.28M	120.76M
Other Expenses	21.85M	33.39M	15K	134K	250K	82K	22K	-64K	-35K
Operating Expenses	464.17M	630.76M	553.86M	466.66M	489.67M	714.59M	483.51M	273.15M	160.16M
Interest Expense	n/a	n/a	14.19M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	44.6M	11.18M	5.27M
Cost & Expenses	473.61M	666.69M	554.67M	467.22M	490.23M	714.99M	483.51M	273.15M	160.16M
Income Tax Expense	n/a	n/a	-29.52M	-7.07M	15.52M	-30.09M	20.36M	-3.63M	-1.49M
Shares Outstanding (Basic)	60.77M	59.84M	59.31M	58.67M	51.98M	50.83M	46.12M	38.1M	33.47M
Shares Outstanding (Diluted)	60.77M	59.84M	59.31M	58.67M	53M	50.83M	46.12M	38.11M	33.49M
EPS (Basic)	-6.59	-9.05	-8.49	-7.68	11.66	-12.79	-8.08	-7.09	-4.75
EPS (Diluted)	-6.59	-9.05	-8.49	-7.68	11.43	-12.79	-8.08	-7.09	-4.75
EBITDA	-409.49M	-545.07M	-545.87M	-456.73M	626.6M	-705.84M	-392.1M	-269.62M	-160.16M
EBIT	-410.52M	-546.46M	-546.99M	-460.91M	623.97M	-708.12M	-393.24M	-270.12M	-158.99M
Depreciation & Amortization	1.03M	1.39M	1.12M	4.18M	2.63M	2.28M	1.1M	500K	281K